serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.252 Cerebellar Diseases .
C10.228.140.252.190 Cerebellar Ataxia .
C10.228.140.252.190.530 Spinocerebellar Ataxias .
C10.228.140.252.700 Spinocerebellar Degenerations .
C10.228.140.252.700.700 Spinocerebellar Ataxias .
C10.228.854 Spinal Cord Diseases .
C10.228.854.787 Spinocerebellar Degenerations .
C10.228.854.787.875 Spinocerebellar Ataxias .
C10.574 Neurodegenerative Diseases .
C10.574.500 Heredodegenerative Disorders, Nervous System .
C10.574.500.825 Spinocerebellar Degenerations .
C10.574.500.825.700 Spinocerebellar Ataxias .
C10.597 Neurologic Manifestations .
C10.597.350 Dyskinesias .
C10.597.350.090 Ataxia .
C10.597.350.090.500 Cerebellar Ataxia .
C10.597.350.090.500.530 Spinocerebellar Ataxias .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.400 Heredodegenerative Disorders, Nervous System .
C16.320.400.780 Spinocerebellar Degenerations .
C16.320.400.780.875 Spinocerebellar Ataxias .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.100 Amino Alcohols .
D02.033.100.291 Ethanolamines .
D02.033.100.291.630 Procaterol .
D02.033.100.624 Propanolamines .
D02.033.100.624.698 Phenoxypropanolamines .
D02.033.100.624.698.207 Carteolol .
D02.033.755 Propanols .
D02.033.755.624 Propanolamines .
D02.033.755.624.698 Phenoxypropanolamines .
D02.033.755.624.698.207 Carteolol .
D02.092 Amines .
D02.092.063 Amino Alcohols .
D02.092.063.291 Ethanolamines .
D02.092.063.291.647 Procaterol .
D02.092.063.624 Propanolamines .
D02.092.063.624.698 Phenoxypropanolamines .
D02.092.063.624.698.207 Carteolol .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.606 Piperazines .
D03.383.606.170 Aripiprazole .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.810 Quinolines .
D03.633.100.810.350 Hydroxyquinolines .
D03.633.100.810.350.700 Procaterol .
D03.633.100.810.835 Quinolones .
D03.633.100.810.835.122 Aripiprazole .
D03.633.100.810.835.188 Carteolol .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Procaterol .
(R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone .
CI-888 .
OPC-2009 .
Pro-Air .
Procaterol Hydrochloride .
Procaterol Monohydrochloride .
Procaterol Monohydrochloride, (R*,R*)-(+)-Isomer .
Procaterol Monohydrochloride, (R*,R*)-(+-)-Isomer .
Procaterol Monohydrochloride, (R*,R*)-(-)-Isomer .
Procaterol Monohydrochloride, (R*,S*)-(+)-Isomer .
Procaterol Monohydrochloride, (R*,S*)-(-)-Isomer .
Procaterol, (R*,R*)-(+-)-Isomer .
Procaterol, (R*,S*)-(-)-Isomer .
CI 888 .
CI888 .
Hydrochloride, Procaterol .
Monohydrochloride, Procaterol .
OPC 2009 .
OPC2009 .
Pro Air .
ProAir .
A long-acting beta-2-adrenergic receptor agonist. .
1.00
1277
 
Carteolol .
Carteolol Hydrochloride .
Carteolol Monohydrochloride .
OPC-1085 .
Hydrochloride, Carteolol .
Monohydrochloride, Carteolol .
OPC 1085 .
OPC1085 .
A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. .
0.50
3317
 
Aripiprazole .
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone .
Abilify .
Aripiprazol .
OPC 14597 .
OPC-14597 .
14597, OPC .
An antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. .
0.43
41944
 
Spinocerebellar Ataxias .
Autosomal Dominant Cerebellar Ataxia, Type II .
Cerebellar Degeneration with Slow Eye Movements .
Cerebelloparenchymal Disorder I .
Dominantly-Inherited Spinocerebellar Ataxias .
Menzel Type OPCA .
OPCA with Macular Degeneration and External Ophthalmoplegia .
OPCA with Retinal Degeneration .
Olivopontocerebellar Atrophy 2 .
Olivopontocerebellar Atrophy I .
Olivopontocerebellar Atrophy II .
Olivopontocerebellar Atrophy III .
Olivopontocerebellar Atrophy IV .
Olivopontocerebellar Atrophy, Holguin Type .
SCA1 22058 .
Schut-Haymaker Type OPCA .
Spinocerebellar Ataxia 1 .
Spinocerebellar Ataxia 2 .
Spinocerebellar Ataxia 4 .
Spinocerebellar Ataxia 5 .
Spinocerebellar Ataxia 6 .
Spinocerebellar Ataxia 7 .
Spinocerebellar Ataxia with Slow Eye Movements .
Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy .
Spinocerebellar Ataxia, Cuban Type .
Spinocerebellar Ataxia-1 .
Spinocerebellar Ataxia-2 .
Spinocerebellar Ataxia-4 .
Spinocerebellar Ataxia-5 .
Spinocerebellar Ataxia-6 .
Spinocerebellar Ataxia-7 .
Spinocerebellar Ataxias, Dominantly-Inherited .
Spinocerebellar Atrophy 2 .
Spinocerebellar Atrophy I .
Spinocerebellar Atrophy II .
Spinocerebellar Degeneration with Slow Eye Movements .
Type 1 Spinocerebellar Ataxia .
Type 2 Spinocerebellar Ataxia .
Type 4 Spinocerebellar Ataxia .
Type 5 Spinocerebellar Ataxia .
Type 6 Spinocerebellar Ataxia .
Type 7 Spinocerebellar Ataxia .
Wadia Swami Syndrome .
Wadia-Swami Syndrome .
Ataxia 1, Spinocerebellar .
Ataxia 2, Spinocerebellar .
Ataxia 2s, Spinocerebellar .
Ataxia 4, Spinocerebellar .
Ataxia 4s, Spinocerebellar .
Ataxia 5, Spinocerebellar .
Ataxia 5s, Spinocerebellar .
Ataxia 6, Spinocerebellar .
Ataxia 6s, Spinocerebellar .
Ataxia 7, Spinocerebellar .
Ataxia 7s, Spinocerebellar .
Ataxia, Dominantly-Inherited Spinocerebellar .
Ataxia, Spinocerebellar .
Ataxias, Dominantly-Inherited Spinocerebellar .
Ataxias, Spinocerebellar .
Atrophies, Spinocerebellar .
Atrophy 2, Olivopontocerebellar .
Atrophy 2, Spinocerebellar .
Atrophy 2s, Olivopontocerebellar .
Atrophy 2s, Spinocerebellar .
Atrophy I, Olivopontocerebellar .
Atrophy I, Spinocerebellar .
Atrophy II, Olivopontocerebellar .
Atrophy II, Spinocerebellar .
Atrophy III, Olivopontocerebellar .
Atrophy IIs, Olivopontocerebellar .
Atrophy IIs, Spinocerebellar .
Atrophy IV, Olivopontocerebellar .
Atrophy IVs, Olivopontocerebellar .
Atrophy, Spinocerebellar .
Cerebelloparenchymal Disorder Is .
Dominantly Inherited Spinocerebellar Ataxias .
Dominantly-Inherited Spinocerebellar Ataxia .
II, Olivopontocerebellar Atrophy .
II, Spinocerebellar Atrophy .
IIs, Olivopontocerebellar Atrophy .
IIs, Spinocerebellar Atrophy .
OPCA, Menzel Type .
OPCA, Schut-Haymaker Type .
Olivopontocerebellar Atrophy 2s .
Olivopontocerebellar Atrophy IIIs .
Olivopontocerebellar Atrophy IIs .
Olivopontocerebellar Atrophy IVs .
Olivopontocerebellar Atrophy Is .
SCA1s .
Schut Haymaker Type OPCA .
Spinocerebellar Ataxia .
Spinocerebellar Ataxia 1s .
Spinocerebellar Ataxia 2s .
Spinocerebellar Ataxia 4s .
Spinocerebellar Ataxia 5s .
Spinocerebellar Ataxia 6s .
Spinocerebellar Ataxia 7s .
Spinocerebellar Ataxia, Dominantly-Inherited .
Spinocerebellar Ataxias, Dominantly Inherited .
Spinocerebellar Atrophy .
Spinocerebellar Atrophy 2s .
Spinocerebellar Atrophy IIs .
Spinocerebellar Atrophy Is .
Swami Syndrome, Wadia .
Syndrome, Wadia Swami .
Syndrome, Wadia-Swami .
Spinocerebellar Ataxia Type 1 .
Spinocerebellar Ataxia Type 2 .
Spinocerebellar Ataxia Type 4 .
Spinocerebellar Ataxia Type 5 .
Spinocerebellar Ataxia Type 6 .
Spinocerebellar Ataxia Type 7 .
Spinocerebellar Atrophies .
A group of dominantly inherited, predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43) .
0.40
401952